- Home
- SMTC vs FOLD Comparison
SMTC vs FOLD Comparison
Compare SMTC & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTC
- FOLD
- Stock Information
- Founded
- SMTC 1960
- FOLD 2002
- Country
- SMTC United States
- FOLD United States
- Employees
- SMTC N/A
- FOLD N/A
- Industry
- SMTC Semiconductors
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- SMTC Technology
- FOLD Health Care
- Exchange
- SMTC Nasdaq
- FOLD Nasdaq
- Market Cap
- SMTC 3.3B
- FOLD 2.9B
- IPO Year
- SMTC N/A
- FOLD 2007
- Fundamental
- Price
- SMTC $35.05
- FOLD $8.43
- Analyst Decision
- SMTC Strong Buy
- FOLD Strong Buy
- Analyst Count
- SMTC 12
- FOLD 9
- Target Price
- SMTC $62.91
- FOLD $17.00
- AVG Volume (30 Days)
- SMTC 2.8M
- FOLD 2.5M
- Earning Date
- SMTC 03-13-2025
- FOLD 05-08-2025
- Dividend Yield
- SMTC N/A
- FOLD N/A
- EPS Growth
- SMTC N/A
- FOLD N/A
- EPS
- SMTC N/A
- FOLD N/A
- Revenue
- SMTC $909,287,000.00
- FOLD $528,294,999.00
- Revenue This Year
- SMTC $19.87
- FOLD $21.91
- Revenue Next Year
- SMTC $11.74
- FOLD $22.22
- P/E Ratio
- SMTC N/A
- FOLD N/A
- Revenue Growth
- SMTC 4.67
- FOLD 32.29
- 52 Week Low
- SMTC $27.25
- FOLD $8.36
- 52 Week High
- SMTC $79.52
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- SMTC 40.33
- FOLD 35.37
- Support Level
- SMTC $39.11
- FOLD $8.40
- Resistance Level
- SMTC $41.49
- FOLD $9.26
- Average True Range (ATR)
- SMTC 2.02
- FOLD 0.25
- MACD
- SMTC 0.65
- FOLD -0.04
- Stochastic Oscillator
- SMTC 32.50
- FOLD 7.78
About SMTC Semtech Corporation
Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments' 1) Signal Integrity, 2) Advanced Protection and Sensing, 3) IoT System and 4) IoT Connected Services. The majority of the company's revenue is earned through Advanced Protection and Sensing Products segment. Geographically majority of the company's revenue is earned from Asia Pacific region.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.